A phase I safety and pharmacologic study of a twice weekly dosing regimen of the oral taxane BMS-275133

L.E. Broker, SA Veltkamp, E.I. Heath, BC Kuenen, H. Gall, L. Astier, S. Parker, L. Kayitalire, P.M. Lorusso, J.H.M. Schellens, G. Giaccone

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)3906-3912
Number of pages7
JournalClinical Cancer Research
Issue number13
Publication statusPublished - 2007

Cite this